InsidersTradesSigma
Track the Elicera Therapeutics AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Elicera Therapeutics AB has recorded 3 insider filings. Market capitalisation: €172.2m. The latest transaction was filed on 12 March 2025 (Purchase). Among the most active insiders: Margareth Jorvid. Every trade is openly available.
3
Insider Decl.
n/a
Thresholds
€11,763
3 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 March 2025
Declarations3 total
21,700 shares@ €0.16850.0024% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M484-1
43,211 shares@ €0.16850.0048% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M442-1
18,000 shares@ €0.04570.0005% mcap100.0% of flowOptionISIN SE0021626314FI:A003M381-1
3 of 3 declarations
About Elicera Therapeutics AB
Elicera Therapeutics AB is a biopharmaceutical company focused on developing innovative therapies based on advanced technologies. It specializes in the treatment of cancer and other serious diseases.